Marta Zola, Cristina Briamonte, Umberto Lorenzi, Federica Machetta, Federico M Grignolo, Antonio M Fea Ophthalmic Eye Hospital, Department of Surgical Sciences, University of Turin, Italy Purpose: The purpose of this study was to report the functional and anatomical outcomes of a prospective study resulting from repeated dexamethasone intravitreal implants in patients with uveitic refractory macular edema.Methods: Twelve eyes of 9 patients with intermediate and posterior noninfectious inflammatory uveitis complicated with refractory macular edema were regularly reviewed after a dexamethasone intravitreal implant. Patients were examined at baseline, 30, 90, 135, and 180 days with best-corrected visual acuity (BCVA), complete slit-lamp...
Purpose: This study evaluated the effect of intravitreal dexamethasone implant (IDI; Ozurdex) inject...
OBJECTIVE: To evaluate the safety and efficacy of 1 or 2 treatments with dexamethasone intravitreal...
Objective: To evaluate the safety and efficacy of 1 or 2 treatments with dexamethasone intravitreal ...
Purpose: To retrospectively study the efficacy of a single 0.7-mg dexamethasone intravitreal implant...
Purpose: To retrospectively study the efficacy of a single 0.7-mg dexamethasone intravitreal implant...
Objective: The objective of this study was to evaluate the efficacy of intravitreal dexamethasone im...
Macular edema (ME) is a common cause of visual loss among eyes with uveitis, and its management can ...
Macular edema (ME) is a common cause of visual loss among eyes with uveitis, and its management can ...
ABSTRACT Purpose: To evaluate the use of a slow-release dexamethasone 0.7-mg intravitreal implant fo...
ABSTRACT Purpose: To evaluate the use of a slow-release dexamethasone 0.7-mg intravitreal implant fo...
PURPOSE: To investigate the efficacy of the intravitreal dexamethasone implant as the treatment for ...
PURPOSE: To describe the long-term outcome of eyes with uveitis after repeated treatment with dexame...
PURPOSE: To describe the long-term outcome of eyes with uveitis after repeated treatment with dexame...
Purpose: To evaluate the real-life efficacy and safety of the intravitreal dexamethasone implant (DE...
Purpose: To study the efficacy of a single 0.7 mg dexamethasone intravitreal implant in vitrectomize...
Purpose: This study evaluated the effect of intravitreal dexamethasone implant (IDI; Ozurdex) inject...
OBJECTIVE: To evaluate the safety and efficacy of 1 or 2 treatments with dexamethasone intravitreal...
Objective: To evaluate the safety and efficacy of 1 or 2 treatments with dexamethasone intravitreal ...
Purpose: To retrospectively study the efficacy of a single 0.7-mg dexamethasone intravitreal implant...
Purpose: To retrospectively study the efficacy of a single 0.7-mg dexamethasone intravitreal implant...
Objective: The objective of this study was to evaluate the efficacy of intravitreal dexamethasone im...
Macular edema (ME) is a common cause of visual loss among eyes with uveitis, and its management can ...
Macular edema (ME) is a common cause of visual loss among eyes with uveitis, and its management can ...
ABSTRACT Purpose: To evaluate the use of a slow-release dexamethasone 0.7-mg intravitreal implant fo...
ABSTRACT Purpose: To evaluate the use of a slow-release dexamethasone 0.7-mg intravitreal implant fo...
PURPOSE: To investigate the efficacy of the intravitreal dexamethasone implant as the treatment for ...
PURPOSE: To describe the long-term outcome of eyes with uveitis after repeated treatment with dexame...
PURPOSE: To describe the long-term outcome of eyes with uveitis after repeated treatment with dexame...
Purpose: To evaluate the real-life efficacy and safety of the intravitreal dexamethasone implant (DE...
Purpose: To study the efficacy of a single 0.7 mg dexamethasone intravitreal implant in vitrectomize...
Purpose: This study evaluated the effect of intravitreal dexamethasone implant (IDI; Ozurdex) inject...
OBJECTIVE: To evaluate the safety and efficacy of 1 or 2 treatments with dexamethasone intravitreal...
Objective: To evaluate the safety and efficacy of 1 or 2 treatments with dexamethasone intravitreal ...